Clinical Chemistry AACC Online Job Center
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 50: 1640-1649, 2004. First published July 1, 2004; 10.1373/clinchem.2004.033811
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
clinchem.2004.033811v1
50/9/1640    most recent
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via ISI Web of Science (6)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Van Campenhout, A.
Right arrow Articles by Manuel-y-Keenoy, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Van Campenhout, A.
Right arrow Articles by Manuel-y-Keenoy, B.
Related Collections
Right arrow Endocrinology and Metabolism
(Clinical Chemistry. 2004;50:1640-1649.)
© 2004 American Association for Clinical Chemistry, Inc.


Endocrinology and Metabolism

Effects of in Vitro Glycation on Fe3+ Binding and Fe3+ Isoforms of Transferrin

Ann Van Campenhout1, Christel Van Campenhout2, Albert René Lagrou3 and Begoña Manuel-y-Keenoy1,a

1 Laboratory of Endocrinology, Antwerp Metabolic Research Unit, University of Antwerp, Wilrijk, Belgium.
2 Laboratory of Immunology and Protein Chemistry, University Hospital of Antwerp, Edegem, Belgium.
3 Laboratory of Human Biochemistry, Department of Pharmaceutical Sciences, University of Antwerp, Antwerp, Belgium.

aAddress correspondence to this author at: Laboratory of Endocrinology, Antwerp Metabolic Research Unit, University of Antwerp T 4.37, Universiteitsplein 1, B-2610 Wilrijk, Belgium. Fax 32-3-820-2574; e-mail begona.manuelykeenoy{at}ua.ac.be.

Background: In diabetes, protein function is altered by glycation, but the impact on the Fe3+ binding and antioxidant functions of transferrin (Tf) is largely unknown. The aim of the present study was to investigate the effects of glycation on the distribution of Fe3+ on the two Fe3+-binding sites of Tf.

Methods: In vitro glycation of Tf was accomplished by preincubation with glucose for 14 days. Tf was loaded with Fe3+ compounds to achieve theoretical Tf Fe3+ saturations of 32%, 64%, and 96% (monitored by spectrophotometry). Fe3+-Tf isoforms were separated by isoelectric focusing.

Results: Fe3+ binding was highest when Tf was incubated with Fe:nitrilotriacetic acid and reached a steady state overnight. Increasing the Fe3+ load led to a shift of isoform profile toward the diferric form (Fe2-Tf): in freshly prepared Tf, Fe2-Tf represented 6%, 30%, and 66% of all isoforms at 32%, 64%, and 96% theoretical Fe3+ saturation, respectively. Fe3+ was equally distributed to the monoferric Tf forms with Fe3+ bound to the amino (Fe1N-Tf) and carboxy termini (Fe1C-Tf). Glycation decreased binding of Fe3+ to Tf (monitored at 450 nm). At low theoretical Fe3+ saturation (32%), glycation increased the mean (SD) proportion of Fe2-Tf: 18 (3)% in the presence of 33.3 mmol/L glucose vs 12 (4)% with 0 mmol/L glucose (P = 0.01). In contrast, at 96% theoretical Fe3+ saturation, Fe2-Tf decreased linearly with increasing glycation (r = 0.97; P = 0.008). Preincubation, independent of glycation, favored the Fe1N-Tf isoform at 64% theoretical Fe3+ saturation [27 (0.7)% vs 23 (1.1)% of the Fe1C-Tf isoform; P = 0.009].

Conclusions: Glycation impairs Fe3+ binding and affects Fe3+-Tf isoform distribution depending on concentration. The diagnostic implications of these results need further elucidation in clinical studies.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by the American Association for Clinical Chemistry.